Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 274(53): 37809-14, 1999 Dec 31.
Article in English | MEDLINE | ID: mdl-10608843

ABSTRACT

There are key differences between the amino acid residues of the RGD loops and the C termini of echistatin, a potent antagonist of alpha(IIb)beta(3), alpha(v)beta(3) and alpha(5)beta(1), and eristostatin, a similar disintegrin selectively inhibiting alpha(IIb)beta(3). In order to identify echistatin motifs required for selective recognition of alpha(v)beta(3) and alpha(5)beta(1) integrins, we expressed recombinant echistatin, eristostatin, and 15 hybrid molecules. We tested them for their ability to inhibit adhesion of different cell lines to fibronectin and von Willebrand factor and to express ligand-induced binding site epitope. The results showed that Asp(27) and Met(28) support recognition of both alpha(v)beta(3) and alpha(5)beta(1). Replacement of Met(28) with Asn completely abolished echistatin's ability to recognize each of the integrins, while replacement of Met(28) with Leu selectively decreased echistatin's ability to recognize alpha(5)beta(1) only. Eristostatin in which C-terminal WNG sequence was substituted with HKGPAT exhibited new activity with alpha(5)beta(1), which was 10-20-fold higher than that of wild type eristostatin. A hypothesis is proposed that the C terminus of echistatin interacts with separate sites on beta(1) and beta(3) integrin molecules.


Subject(s)
Peptides/metabolism , Receptors, Fibronectin/metabolism , Receptors, Vitronectin/metabolism , Amino Acid Sequence , Animals , CHO Cells , Cricetinae , Intercellular Signaling Peptides and Proteins , Molecular Sequence Data , Mutation , Peptides/chemistry , Peptides/genetics , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Sequence Homology, Amino Acid , Viper Venoms/chemistry , Viper Venoms/genetics , Viper Venoms/metabolism
2.
Proc Soc Exp Biol Med ; 219(2): 109-19, 1998 Nov.
Article in English | MEDLINE | ID: mdl-9790167

ABSTRACT

The term "disintegrin" was first used in 1990 to describe a group of viper venom-derived, nonenzymatic small proteins that shared numerous structural and functional properties. These proteins, which have been found in a great number of viper species studied since that time possess both a remarkable sequence homology and an equally notable variability in potency and selectivity in their interactions with integrin receptors. The discovery that small disintegrins may actually have been derived from much larger mosaic proteins possessing catalytic activity, and that species other than snakes (both plant and animal) produce proteins containing disintegrin-like domains, has led to much research related to both the proteins themselves and the receptors to which they bind. The purpose of this review is to discuss the literature and the authors' own data on the structure and function of disintegrins and their relevance to the studies on proteins containing disintegrin-like domains, such as hemorrhagins and ADAMs.


Subject(s)
Disintegrins , Platelet Aggregation Inhibitors , Viper Venoms , Amino Acid Sequence , Animals , Dimerization , Disintegrins/chemistry , Disintegrins/metabolism , Endopeptidases/chemistry , Endopeptidases/metabolism , Humans , Molecular Sequence Data , Platelet Aggregation Inhibitors/chemistry , Platelet Aggregation Inhibitors/metabolism , Sequence Alignment
SELECTION OF CITATIONS
SEARCH DETAIL
...